Reactivity of peripheral blood lymphocytes to oxidized low-density lipoprotein: A novel system to estimate atherosclerosis employing the Cellscan

Clinical Cardiology

Volumn 22, Issue 8, 1999, Pages 526-532

  Zurgil, N ^a,b   Levy, Y ^c   Deutsch, M ^b   Gilburd, B ^c   George, J ^c   Harats, D ^c   Kaufman, M ^b   Shoenfeld, Yehuda ^c,d  

^a Medis El Ltd   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

Atherosclerosis; Cellscan; Coronary heart disease; Fluorescence polarization; Inflammation

Indexed keywords

ANTIOXIDANT; FLUORESCEIN DIACETATE; IMMUNOGLOBULIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMETRY; FEMALE; FLUORESCENCE POLARIZATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IMMUNOGLOBULIN DEPOSITION; IMMUNOMODULATION; IMMUNOREACTIVITY; ISCHEMIC HEART DISEASE; MALE; PERIPHERAL LYMPHOCYTE;

EID: 0032795378     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960220808     Document Type: Article

References (42)

1. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801-809
2. Hegele RA: The pathogenesis of atherosclerosis. Clin Chim Acta 1996;246:21-38
3. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q: Is atherosclerosis an immunologically mediated disease? Immunol Today 1995;16:27-33
4. Libby P, Hansson GK: Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions. Lab Invest 1991;64:5-15
5. Palinski W, Miller E, Witztum JL: Immunization of low density lipoprotein (LDL) deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci USA 1995;92:821-825
6. Sohma Y, Sasano H, Shiga R, Saeki S, Suzuki T, Nagura H, Nose M. Yamamoto T: Accumulation of plasma cells in atherosclerotic lesions of Watanabe heritable hyperlipidemic rats. Proc Natl Acad Sci USA 1995;92:4937-4941
7. Shimokama T, Haraoka S, Watanaba T: Morphological fate and sequelae of human atherosclerosis: Evaluation of immune mechanisms in atherogenesis through immunohistological and ultrastructural analysis. Pathol Int 1995;45:801-814
8. Ameli S, Hultgardh-Nilsson A, Regenstrom J, Calara F, Yana J, Cercek B, Shah PK, Nillson J: Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol 1996;16: 1074-1079
9. Yla-Hettuala SW, Palinski SW, Butler S, Picard D, Steinberg D, Witztum JL: Rabbit and human atherosclerotic lesion contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb 1994;14:32-40
10. Grundy SM: Role of low-density lipoproteins in atherogenesis and development of coronary heart disease. Clin Chem 1995;41: 139-146
11. Holvoet P, Collen D: Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J 1994;8:1279-1284
12. Steinberg DS, Parathasarathy TE, Carew JC, Khoo, Witztum JL: Beyond cholesterol: Modification of low density lipoprotein that increases its atherogenicity. N Engl J Med 1989;320:915-924
13. Witztum J: The oxidation hypothesis of atherosclerosis. Lancet 1994;344:793-795
14. Mironova M, Virella G, Lopes-Virella MF: Isolation and characterization of human antioxidized LDL autoantibodies. Atheroscler Thromb Vasc Biol 1996;16:222-229
15. Stemme S, Faber B, Holm J: T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995;92:3893-3897
16. Hudson L, Hay FC: Mitogenic response. In Practical Immunology, 3rd ed., p. 154. Oxford: Blackwell Publishers, 1989
17. Deutsch M, Weinreb A: Apparatus of high precision repetitive sequential optical measurement of living cells. Cytometry 1994; 16:214-226
18. Kaplan MR, Trubniykov E, Berke G: Fluorescence depolarization as an early measure of lymphocyte stimulation. J Immun Methods 1997;201:15-24
19. Zurgil N, Gerbat S, Langevitz P, Tishler M, Ehrenfeld M, Schoenfeld Y: Intracellular fluorescence polarization measurements by the Cellscan system: Detection of cellular activity in autoimmune disorders. Isr J Med Sci 1997;33:51-57
20. Marder O, Shoval S, Eisenthal A, Fireman E, Skornick Y, Lifschitz-Mercer B, Deutsch M, Tirosh R, Weinreb A: Effect of interleukin (IL)-1α, IL-1β and tumor necrosis factor (TNF)-α on the intracellular fluorescein fluorescence polarization (IFFP) of human lung fibroblasts. Pathobiology 1996;321:1015-2008
21. Eisenthal A, Marder O, Dotan D, Baron S, Lifschitz-Mercer B, Chaitchik S, Tirosh R, Weinreb A, Deutsch M: Decrease of intracellular fluorescein fluorescence polarization in human peripheral blood lymphocytes undergoing stimulation with phytohaemagglutinin (PHA) concanavalin A (Con A), Pokeweed mitogen (PWM) and anti CDS. Biol Cell 1996;86:145-150
22. Eisenthal A, Marder O, Lifschitz-Mercer B, Skornick Y, Fixler D, Avtalyon R, Tirosh R, Deutsch M: Influenza A virus affects the response of human peripheral blood mononuclear cells to phytohaemagglutinin A by altering thecytoskeleton. Pathobiology 1997; 65:69-74
23. George J, Blank M, Hojnic M, Bar-Meir E, Koike T, Matsuura E, Lorber M, Aviram M, Shoenfeld Y: Oxidized low density lipoprotein (oxLDL) but not LDL aggravates the manifestations of antiphospholipid syndrome (APS). Clin Exp Immunol 1997;108(2); 227-233
24. Zurgil N, Deutsch M, Tirosh R, Brodie C: Indication that intracellular fluorescence polarization of lymphocytes is cell cycle dependent. Cell Struct Funct 1996, 21:271-276
25. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Banshad B, Esterson M, Fogelman AM: Minimally modified LDL stimulates monocyte endothelial interactions. J Clin Invest 1990;85: 1260-1266
26. He Y, Kwan WC, Steinbrecher UP: Effects of oxidized low density lipoprotein on endothelin secretion by cultured endothelial cells and macrophages. Atherosclerosis 1996;119:107-118
27. Rajavahishisth TB, Andalibi A, Territo MC: Induction of endothelial cell expression of granulocyte and macrophage colony stimulating factors by modified low density lipoproteins. Nature (Lond.) 1990;344:254-257
28. Nishio E, Arimura S, Watanaba Y: Oxidized LDL induces apoptosis in cultured smooth muscle cells: A possible role for 7-ketocholestrol. Biochem Biophys Res 1996;223:413-418
29. Aviram M: Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants. Eur J Clin Chem Clin Biochem 1996;34:599-608
30. Zhao B: Role of lipoproteins in platelet activation. Blood Coag Fib 1996;7:270-273
31. Heery JM, Kozak M, Stafforini DM, Jones DA, Zimmerman GA, McIntyre TM, Prescott SM: Oxidatively modified LDL contains phospholipids with platelet activating factor like activity and stimulates the growth of smooth muscle cells. J Clin Invest 1995; 96:2322-2330
32. McMurray HF, Parthasarathy HF, Steinberg D: Oxidatively modified low density lipoprotein is a chemoreactant for human T lymphocytes. J Clin Invest 1993;92:1004-1008
33. Cushing SD, Berliner AJ, Valente MC, Territo MC, Navab M, Parhani F, Gerrity R, Schwartz CJ, Fogelman AM: Minimally modified LDL induces monocyte chemotactic factor 1 in human endothelial and smooth muscle cells. Proc Natl Acad Sci USA 1990;87:5134-5138
34. Guyton JR, Lenz ML, Mathews B, Hughes H, Karsan D, Selinger E, Smith CV: Toxicity of oxidized LDL for vascular smooth muscle cells and pariatal protection by antioxidants. Atherosclerosis 1995; 118:237-249
35. Kleindienst R, Xu Q, Willeit J, Wadenberger FR, Weimann S, Wick G: Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am J Pathol 1993;142:1927-1937
36. Frostegard J, Wu R, Giscombe R, Holm G, Letvert AK, Nilsson J: Induction of T-cell activation by oxidized low density lipoprotein. AtherosclerThromb 1992;12:461-467
37. Lizard G, Fournel S, Genestier L, Dhedin N, Chaput C, Flacher M, Mutin M, Panaye G, Revillard JP: Kinetics of plasma membrane and mitochondria alterations in cells undergoing apoptosis. Cytometry 1995;21:275-283
38. Tinkle CW, Lipschitz D, Ponnappan U: Decreased association of p561ck with CD4 may account for lowered tyrosine kinase activity in mitogen-activated human T lymphocytes during aging. Cell Immunol 1998;186:154-160
39. Van Aman SE, Whisler RL: Differential expression of p53 tumor suppressor protein and IL-2 in activated T cells from elderly humans. J Interferon Cytokine Res 1998;18:315-320
40. Malkowska-Zwierez W, Skopinska-Rozewska E, Wroblewski T, Kwarecka M, Pawinska M, Wlodarska B, Polakowski IJ, Pazdur J: Theophylline-resistant and theophylline-sensitive "early" and "late" E rosette-forming cells in young and aged humans. Mech Aging Dev 1987;40(1):1-8
41. George J, Afek A, Gilburd B, Blank M, Levy Y, Aron-Maor A, Levkovitz H, Shaish A, Goldberg I, Kopolovic J, Harats D, Shoenfeld Y: Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta 2-glycoprotein I. Circulation 1998;98: 1108-1115
42. Muhlestein JB, Anderson JL, Hammond EH, Zhao I, Trehan S, Schwobe EP, Cariquist JF: Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998;97: 633-636